[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Microbiomes Market Growth (Status and Outlook) 2023-2029

March 2023 | 120 pages | ID: G3D63B8DE8D3EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Microbiomes Industry Forecast” looks at past sales and reviews total world Microbiomes sales in 2022, providing a comprehensive analysis by region and market sector of projected Microbiomes sales for 2023 through 2029. With Microbiomes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microbiomes industry.

This Insight Report provides a comprehensive analysis of the global Microbiomes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microbiomes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microbiomes market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microbiomes and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microbiomes.

The global Microbiomes market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Microbiomes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Microbiomes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Microbiomes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Microbiomes players cover 4D Pharma, Enterome BioScience, Evelo Biosciences, Ferring, Osel, Second Genome, Seres Therapeutics, Synlogic and Synthetic Biologics and Vedanta Biosciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Microbiomes market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Gastrointestinal Microbiome
  • Genitourinary Microbiome
  • Skin Microbiome
  • Respiratory Microbiome
  • Other
Segmentation by application
  • Testing
  • Treatment
  • Diagnosis
  • Technology Platform
  • Probiotics
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • 4D Pharma
  • Enterome BioScience
  • Evelo Biosciences
  • Ferring
  • Osel
  • Second Genome
  • Seres Therapeutics
  • Synlogic
  • Synthetic Biologics and Vedanta Biosciences
  • Vedanta
  • Rebiotix
  • ActoGeniX
  • Enterologics
  • Metabogen
  • Metabiomics
  • Ritter Pharmaceuticals
  • AvidBiotics
  • Symberix
  • Miomics
  • Symbiotix Biotherapies
  • MicroBiome Therapeutics LLC
  • SciBac Inc
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Microbiomes Market Size 2018-2029
  2.1.2 Microbiomes Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Microbiomes Segment by Type
  2.2.1 Gastrointestinal Microbiome
  2.2.2 Genitourinary Microbiome
  2.2.3 Skin Microbiome
  2.2.4 Respiratory Microbiome
  2.2.5 Other
2.3 Microbiomes Market Size by Type
  2.3.1 Microbiomes Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Microbiomes Market Size Market Share by Type (2018-2023)
2.4 Microbiomes Segment by Application
  2.4.1 Testing
  2.4.2 Treatment
  2.4.3 Diagnosis
  2.4.4 Technology Platform
  2.4.5 Probiotics
  2.4.6 Other
2.5 Microbiomes Market Size by Application
  2.5.1 Microbiomes Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Microbiomes Market Size Market Share by Application (2018-2023)

3 MICROBIOMES MARKET SIZE BY PLAYER

3.1 Microbiomes Market Size Market Share by Players
  3.1.1 Global Microbiomes Revenue by Players (2018-2023)
  3.1.2 Global Microbiomes Revenue Market Share by Players (2018-2023)
3.2 Global Microbiomes Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MICROBIOMES BY REGIONS

4.1 Microbiomes Market Size by Regions (2018-2023)
4.2 Americas Microbiomes Market Size Growth (2018-2023)
4.3 APAC Microbiomes Market Size Growth (2018-2023)
4.4 Europe Microbiomes Market Size Growth (2018-2023)
4.5 Middle East & Africa Microbiomes Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Microbiomes Market Size by Country (2018-2023)
5.2 Americas Microbiomes Market Size by Type (2018-2023)
5.3 Americas Microbiomes Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Microbiomes Market Size by Region (2018-2023)
6.2 APAC Microbiomes Market Size by Type (2018-2023)
6.3 APAC Microbiomes Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Microbiomes by Country (2018-2023)
7.2 Europe Microbiomes Market Size by Type (2018-2023)
7.3 Europe Microbiomes Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Microbiomes by Region (2018-2023)
8.2 Middle East & Africa Microbiomes Market Size by Type (2018-2023)
8.3 Middle East & Africa Microbiomes Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MICROBIOMES MARKET FORECAST

10.1 Global Microbiomes Forecast by Regions (2024-2029)
  10.1.1 Global Microbiomes Forecast by Regions (2024-2029)
  10.1.2 Americas Microbiomes Forecast
  10.1.3 APAC Microbiomes Forecast
  10.1.4 Europe Microbiomes Forecast
  10.1.5 Middle East & Africa Microbiomes Forecast
10.2 Americas Microbiomes Forecast by Country (2024-2029)
  10.2.1 United States Microbiomes Market Forecast
  10.2.2 Canada Microbiomes Market Forecast
  10.2.3 Mexico Microbiomes Market Forecast
  10.2.4 Brazil Microbiomes Market Forecast
10.3 APAC Microbiomes Forecast by Region (2024-2029)
  10.3.1 China Microbiomes Market Forecast
  10.3.2 Japan Microbiomes Market Forecast
  10.3.3 Korea Microbiomes Market Forecast
  10.3.4 Southeast Asia Microbiomes Market Forecast
  10.3.5 India Microbiomes Market Forecast
  10.3.6 Australia Microbiomes Market Forecast
10.4 Europe Microbiomes Forecast by Country (2024-2029)
  10.4.1 Germany Microbiomes Market Forecast
  10.4.2 France Microbiomes Market Forecast
  10.4.3 UK Microbiomes Market Forecast
  10.4.4 Italy Microbiomes Market Forecast
  10.4.5 Russia Microbiomes Market Forecast
10.5 Middle East & Africa Microbiomes Forecast by Region (2024-2029)
  10.5.1 Egypt Microbiomes Market Forecast
  10.5.2 South Africa Microbiomes Market Forecast
  10.5.3 Israel Microbiomes Market Forecast
  10.5.4 Turkey Microbiomes Market Forecast
  10.5.5 GCC Countries Microbiomes Market Forecast
10.6 Global Microbiomes Forecast by Type (2024-2029)
10.7 Global Microbiomes Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 4D Pharma
  11.1.1 4D Pharma Company Information
  11.1.2 4D Pharma Microbiomes Product Offered
  11.1.3 4D Pharma Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 4D Pharma Main Business Overview
  11.1.5 4D Pharma Latest Developments
11.2 Enterome BioScience
  11.2.1 Enterome BioScience Company Information
  11.2.2 Enterome BioScience Microbiomes Product Offered
  11.2.3 Enterome BioScience Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Enterome BioScience Main Business Overview
  11.2.5 Enterome BioScience Latest Developments
11.3 Evelo Biosciences
  11.3.1 Evelo Biosciences Company Information
  11.3.2 Evelo Biosciences Microbiomes Product Offered
  11.3.3 Evelo Biosciences Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Evelo Biosciences Main Business Overview
  11.3.5 Evelo Biosciences Latest Developments
11.4 Ferring
  11.4.1 Ferring Company Information
  11.4.2 Ferring Microbiomes Product Offered
  11.4.3 Ferring Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Ferring Main Business Overview
  11.4.5 Ferring Latest Developments
11.5 Osel
  11.5.1 Osel Company Information
  11.5.2 Osel Microbiomes Product Offered
  11.5.3 Osel Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Osel Main Business Overview
  11.5.5 Osel Latest Developments
11.6 Second Genome
  11.6.1 Second Genome Company Information
  11.6.2 Second Genome Microbiomes Product Offered
  11.6.3 Second Genome Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Second Genome Main Business Overview
  11.6.5 Second Genome Latest Developments
11.7 Seres Therapeutics
  11.7.1 Seres Therapeutics Company Information
  11.7.2 Seres Therapeutics Microbiomes Product Offered
  11.7.3 Seres Therapeutics Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Seres Therapeutics Main Business Overview
  11.7.5 Seres Therapeutics Latest Developments
11.8 Synlogic
  11.8.1 Synlogic Company Information
  11.8.2 Synlogic Microbiomes Product Offered
  11.8.3 Synlogic Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Synlogic Main Business Overview
  11.8.5 Synlogic Latest Developments
11.9 Synthetic Biologics and Vedanta Biosciences
  11.9.1 Synthetic Biologics and Vedanta Biosciences Company Information
  11.9.2 Synthetic Biologics and Vedanta Biosciences Microbiomes Product Offered
  11.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Synthetic Biologics and Vedanta Biosciences Main Business Overview
  11.9.5 Synthetic Biologics and Vedanta Biosciences Latest Developments
11.10 Vedanta
  11.10.1 Vedanta Company Information
  11.10.2 Vedanta Microbiomes Product Offered
  11.10.3 Vedanta Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Vedanta Main Business Overview
  11.10.5 Vedanta Latest Developments
11.11 Rebiotix
  11.11.1 Rebiotix Company Information
  11.11.2 Rebiotix Microbiomes Product Offered
  11.11.3 Rebiotix Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Rebiotix Main Business Overview
  11.11.5 Rebiotix Latest Developments
11.12 ActoGeniX
  11.12.1 ActoGeniX Company Information
  11.12.2 ActoGeniX Microbiomes Product Offered
  11.12.3 ActoGeniX Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 ActoGeniX Main Business Overview
  11.12.5 ActoGeniX Latest Developments
11.13 Enterologics
  11.13.1 Enterologics Company Information
  11.13.2 Enterologics Microbiomes Product Offered
  11.13.3 Enterologics Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Enterologics Main Business Overview
  11.13.5 Enterologics Latest Developments
11.14 Metabogen
  11.14.1 Metabogen Company Information
  11.14.2 Metabogen Microbiomes Product Offered
  11.14.3 Metabogen Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.14.4 Metabogen Main Business Overview
  11.14.5 Metabogen Latest Developments
11.15 Metabiomics
  11.15.1 Metabiomics Company Information
  11.15.2 Metabiomics Microbiomes Product Offered
  11.15.3 Metabiomics Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.15.4 Metabiomics Main Business Overview
  11.15.5 Metabiomics Latest Developments
11.16 Ritter Pharmaceuticals
  11.16.1 Ritter Pharmaceuticals Company Information
  11.16.2 Ritter Pharmaceuticals Microbiomes Product Offered
  11.16.3 Ritter Pharmaceuticals Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.16.4 Ritter Pharmaceuticals Main Business Overview
  11.16.5 Ritter Pharmaceuticals Latest Developments
11.17 AvidBiotics
  11.17.1 AvidBiotics Company Information
  11.17.2 AvidBiotics Microbiomes Product Offered
  11.17.3 AvidBiotics Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.17.4 AvidBiotics Main Business Overview
  11.17.5 AvidBiotics Latest Developments
11.18 Symberix
  11.18.1 Symberix Company Information
  11.18.2 Symberix Microbiomes Product Offered
  11.18.3 Symberix Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.18.4 Symberix Main Business Overview
  11.18.5 Symberix Latest Developments
11.19 Miomics
  11.19.1 Miomics Company Information
  11.19.2 Miomics Microbiomes Product Offered
  11.19.3 Miomics Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.19.4 Miomics Main Business Overview
  11.19.5 Miomics Latest Developments
11.20 Symbiotix Biotherapies
  11.20.1 Symbiotix Biotherapies Company Information
  11.20.2 Symbiotix Biotherapies Microbiomes Product Offered
  11.20.3 Symbiotix Biotherapies Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.20.4 Symbiotix Biotherapies Main Business Overview
  11.20.5 Symbiotix Biotherapies Latest Developments
11.21 MicroBiome Therapeutics LLC
  11.21.1 MicroBiome Therapeutics LLC Company Information
  11.21.2 MicroBiome Therapeutics LLC Microbiomes Product Offered
  11.21.3 MicroBiome Therapeutics LLC Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.21.4 MicroBiome Therapeutics LLC Main Business Overview
  11.21.5 MicroBiome Therapeutics LLC Latest Developments
11.22 SciBac Inc
  11.22.1 SciBac Inc Company Information
  11.22.2 SciBac Inc Microbiomes Product Offered
  11.22.3 SciBac Inc Microbiomes Revenue, Gross Margin and Market Share (2018-2023)
  11.22.4 SciBac Inc Main Business Overview
  11.22.5 SciBac Inc Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Microbiomes Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Gastrointestinal Microbiome
Table 3. Major Players of Genitourinary Microbiome
Table 4. Major Players of Skin Microbiome
Table 5. Major Players of Respiratory Microbiome
Table 6. Major Players of Other
Table 7. Microbiomes Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Microbiomes Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Microbiomes Market Size Market Share by Type (2018-2023)
Table 10. Microbiomes Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Microbiomes Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Microbiomes Market Size Market Share by Application (2018-2023)
Table 13. Global Microbiomes Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Microbiomes Revenue Market Share by Player (2018-2023)
Table 15. Microbiomes Key Players Head office and Products Offered
Table 16. Microbiomes Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Microbiomes Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Microbiomes Market Size Market Share by Regions (2018-2023)
Table 21. Global Microbiomes Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Microbiomes Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Microbiomes Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Microbiomes Market Size Market Share by Country (2018-2023)
Table 25. Americas Microbiomes Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Microbiomes Market Size Market Share by Type (2018-2023)
Table 27. Americas Microbiomes Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Microbiomes Market Size Market Share by Application (2018-2023)
Table 29. APAC Microbiomes Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Microbiomes Market Size Market Share by Region (2018-2023)
Table 31. APAC Microbiomes Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Microbiomes Market Size Market Share by Type (2018-2023)
Table 33. APAC Microbiomes Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Microbiomes Market Size Market Share by Application (2018-2023)
Table 35. Europe Microbiomes Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Microbiomes Market Size Market Share by Country (2018-2023)
Table 37. Europe Microbiomes Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Microbiomes Market Size Market Share by Type (2018-2023)
Table 39. Europe Microbiomes Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Microbiomes Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Microbiomes Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Microbiomes Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Microbiomes Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Microbiomes Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Microbiomes Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Microbiomes Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Microbiomes
Table 48. Key Market Challenges & Risks of Microbiomes
Table 49. Key Industry Trends of Microbiomes
Table 50. Global Microbiomes Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Microbiomes Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Microbiomes Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Microbiomes Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. 4D Pharma Details, Company Type, Microbiomes Area Served and Its Competitors
Table 55. 4D Pharma Microbiomes Product Offered
Table 56. 4D Pharma Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. 4D Pharma Main Business
Table 58. 4D Pharma Latest Developments
Table 59. Enterome BioScience Details, Company Type, Microbiomes Area Served and Its Competitors
Table 60. Enterome BioScience Microbiomes Product Offered
Table 61. Enterome BioScience Main Business
Table 62. Enterome BioScience Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Enterome BioScience Latest Developments
Table 64. Evelo Biosciences Details, Company Type, Microbiomes Area Served and Its Competitors
Table 65. Evelo Biosciences Microbiomes Product Offered
Table 66. Evelo Biosciences Main Business
Table 67. Evelo Biosciences Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Evelo Biosciences Latest Developments
Table 69. Ferring Details, Company Type, Microbiomes Area Served and Its Competitors
Table 70. Ferring Microbiomes Product Offered
Table 71. Ferring Main Business
Table 72. Ferring Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Ferring Latest Developments
Table 74. Osel Details, Company Type, Microbiomes Area Served and Its Competitors
Table 75. Osel Microbiomes Product Offered
Table 76. Osel Main Business
Table 77. Osel Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Osel Latest Developments
Table 79. Second Genome Details, Company Type, Microbiomes Area Served and Its Competitors
Table 80. Second Genome Microbiomes Product Offered
Table 81. Second Genome Main Business
Table 82. Second Genome Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Second Genome Latest Developments
Table 84. Seres Therapeutics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 85. Seres Therapeutics Microbiomes Product Offered
Table 86. Seres Therapeutics Main Business
Table 87. Seres Therapeutics Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Seres Therapeutics Latest Developments
Table 89. Synlogic Details, Company Type, Microbiomes Area Served and Its Competitors
Table 90. Synlogic Microbiomes Product Offered
Table 91. Synlogic Main Business
Table 92. Synlogic Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Synlogic Latest Developments
Table 94. Synthetic Biologics and Vedanta Biosciences Details, Company Type, Microbiomes Area Served and Its Competitors
Table 95. Synthetic Biologics and Vedanta Biosciences Microbiomes Product Offered
Table 96. Synthetic Biologics and Vedanta Biosciences Main Business
Table 97. Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Synthetic Biologics and Vedanta Biosciences Latest Developments
Table 99. Vedanta Details, Company Type, Microbiomes Area Served and Its Competitors
Table 100. Vedanta Microbiomes Product Offered
Table 101. Vedanta Main Business
Table 102. Vedanta Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Vedanta Latest Developments
Table 104. Rebiotix Details, Company Type, Microbiomes Area Served and Its Competitors
Table 105. Rebiotix Microbiomes Product Offered
Table 106. Rebiotix Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Rebiotix Main Business
Table 108. Rebiotix Latest Developments
Table 109. ActoGeniX Details, Company Type, Microbiomes Area Served and Its Competitors
Table 110. ActoGeniX Microbiomes Product Offered
Table 111. ActoGeniX Main Business
Table 112. ActoGeniX Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. ActoGeniX Latest Developments
Table 114. Enterologics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 115. Enterologics Microbiomes Product Offered
Table 116. Enterologics Main Business
Table 117. Enterologics Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Enterologics Latest Developments
Table 119. Metabogen Details, Company Type, Microbiomes Area Served and Its Competitors
Table 120. Metabogen Microbiomes Product Offered
Table 121. Metabogen Main Business
Table 122. Metabogen Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. Metabogen Latest Developments
Table 124. Metabiomics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 125. Metabiomics Microbiomes Product Offered
Table 126. Metabiomics Main Business
Table 127. Metabiomics Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. Metabiomics Latest Developments
Table 129. Ritter Pharmaceuticals Details, Company Type, Microbiomes Area Served and Its Competitors
Table 130. Ritter Pharmaceuticals Microbiomes Product Offered
Table 131. Ritter Pharmaceuticals Main Business
Table 132. Ritter Pharmaceuticals Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 133. Ritter Pharmaceuticals Latest Developments
Table 134. AvidBiotics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 135. AvidBiotics Microbiomes Product Offered
Table 136. AvidBiotics Main Business
Table 137. AvidBiotics Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 138. AvidBiotics Latest Developments
Table 139. Symberix Details, Company Type, Microbiomes Area Served and Its Competitors
Table 140. Symberix Microbiomes Product Offered
Table 141. Symberix Main Business
Table 142. Symberix Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 143. Symberix Latest Developments
Table 144. Miomics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 145. Miomics Microbiomes Product Offered
Table 146. Miomics Main Business
Table 147. Miomics Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 148. Miomics Latest Developments
Table 149. Symbiotix Biotherapies Details, Company Type, Microbiomes Area Served and Its Competitors
Table 150. Symbiotix Biotherapies Microbiomes Product Offered
Table 151. Symbiotix Biotherapies Main Business
Table 152. Symbiotix Biotherapies Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 153. Symbiotix Biotherapies Latest Developments
Table 154. MicroBiome Therapeutics LLC Details, Company Type, Microbiomes Area Served and Its Competitors
Table 155. MicroBiome Therapeutics LLC Microbiomes Product Offered
Table 156. MicroBiome Therapeutics LLC Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 157. MicroBiome Therapeutics LLC Main Business
Table 158. MicroBiome Therapeutics LLC Latest Developments
Table 159. SciBac Inc Details, Company Type, Microbiomes Area Served and Its Competitors
Table 160. SciBac Inc Microbiomes Product Offered
Table 161. SciBac Inc Main Business
Table 162. SciBac Inc Microbiomes Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 163. SciBac Inc Latest Developments

LIST OF FIGURES

Figure 1. Microbiomes Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Microbiomes Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Microbiomes Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Microbiomes Sales Market Share by Country/Region (2022)
Figure 8. Microbiomes Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Microbiomes Market Size Market Share by Type in 2022
Figure 10. Microbiomes in Testing
Figure 11. Global Microbiomes Market: Testing (2018-2023) & ($ Millions)
Figure 12. Microbiomes in Treatment
Figure 13. Global Microbiomes Market: Treatment (2018-2023) & ($ Millions)
Figure 14. Microbiomes in Diagnosis
Figure 15. Global Microbiomes Market: Diagnosis (2018-2023) & ($ Millions)
Figure 16. Microbiomes in Technology Platform
Figure 17. Global Microbiomes Market: Technology Platform (2018-2023) & ($ Millions)
Figure 18. Microbiomes in Probiotics
Figure 19. Global Microbiomes Market: Probiotics (2018-2023) & ($ Millions)
Figure 20. Microbiomes in Other
Figure 21. Global Microbiomes Market: Other (2018-2023) & ($ Millions)
Figure 22. Global Microbiomes Market Size Market Share by Application in 2022
Figure 23. Global Microbiomes Revenue Market Share by Player in 2022
Figure 24. Global Microbiomes Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Microbiomes Market Size 2018-2023 ($ Millions)
Figure 26. APAC Microbiomes Market Size 2018-2023 ($ Millions)
Figure 27. Europe Microbiomes Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Microbiomes Market Size 2018-2023 ($ Millions)
Figure 29. Americas Microbiomes Value Market Share by Country in 2022
Figure 30. United States Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Microbiomes Market Size Market Share by Region in 2022
Figure 35. APAC Microbiomes Market Size Market Share by Type in 2022
Figure 36. APAC Microbiomes Market Size Market Share by Application in 2022
Figure 37. China Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Microbiomes Market Size Market Share by Country in 2022
Figure 44. Europe Microbiomes Market Size Market Share by Type (2018-2023)
Figure 45. Europe Microbiomes Market Size Market Share by Application (2018-2023)
Figure 46. Germany Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Microbiomes Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Microbiomes Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Microbiomes Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Microbiomes Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Microbiomes Market Size 2024-2029 ($ Millions)
Figure 60. APAC Microbiomes Market Size 2024-2029 ($ Millions)
Figure 61. Europe Microbiomes Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Microbiomes Market Size 2024-2029 ($ Millions)
Figure 63. United States Microbiomes Market Size 2024-2029 ($ Millions)
Figure 64. Canada Microbiomes Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Microbiomes Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Microbiomes Market Size 2024-2029 ($ Millions)
Figure 67. China Microbiomes Market Size 2024-2029 ($ Millions)
Figure 68. Japan Microbiomes Market Size 2024-2029 ($ Millions)
Figure 69. Korea Microbiomes Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Microbiomes Market Size 2024-2029 ($ Millions)
Figure 71. India Microbiomes Market Size 2024-2029 ($ Millions)
Figure 72. Australia Microbiomes Market Size 2024-2029 ($ Millions)
Figure 73. Germany Microbiomes Market Size 2024-2029 ($ Millions)
Figure 74. France Microbiomes Market Size 2024-2029 ($ Millions)
Figure 75. UK Microbiomes Market Size 2024-2029 ($ Millions)
Figure 76. Italy Microbiomes Market Size 2024-2029 ($ Millions)
Figure 77. Russia Microbiomes Market Size 2024-2029 ($ Millions)
Figure 78. Spain Microbiomes Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Microbiomes Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Microbiomes Market Size 2024-2029 ($ Millions)
Figure 81. Israel Microbiomes Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Microbiomes Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Microbiomes Market Size 2024-2029 ($ Millions)
Figure 84. Global Microbiomes Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Microbiomes Market Size Market Share Forecast by Application (2024-2029)


More Publications